Opening book details…
About this Medicine article
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer by Rimawi, Mothaffar F. (author);Niravath, Polly (author);Wang, Tao (author);Rexer, Brent N. (author);Forero, Andres (author);Wolff, Antonio C. (author);Nanda, Rita (author);Storniolo, Anna M. (author);Krop, Ian (author);Goetz, Matthew P. (author);Nangia, Julie R. (author);Jiralerspong, Sao (author);Pavlick, Anne (author);Veeraraghavan, Jamunarani (author);de Angelis, Carmine (author);Gutierrez, Carolina (author);Schiff, Rachel (author);Hilsenbeck, Susan G. (author);Kent Osborne, C. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Rimawi, Mothaffar F. (author);Niravath, Polly (author);Wang, Tao (author);Rexer, Brent N. (author);Forero, Andres (author);Wolff, Antonio C. (author);Nanda, Rita (author);Storniolo, Anna M. (author);Krop, Ian (author);Goetz, Matthew P. (author);Nangia, Julie R. (author);Jiralerspong, Sao (author);Pavlick, Anne (author);Veeraraghavan, Jamunarani (author);de Angelis, Carmine (author);Gutierrez, Carolina (author);Schiff, Rachel (author);Hilsenbeck, Susan G. (author);Kent Osborne, C. (author)
- Publisher
- American Association for Cancer Research Inc.
- Published
- 2020
- Field
- Medicine (Health Sciences)